Publications

CTSN Primary Outcome Papers and Late Breaking Science
Publication Journal
Transcatheter or Surgical Replacement for Failed Bioprosthetic Aortic Valves JAMA Cardiology
Clinical Trial Diversity, Equity & Inclusion: Roadmap of the Cardiothoracic Surgical Trials Network Annals of Thoracic Surgery
Intravenous aviptadil and remdesivir for treatment of COVID-19-associated hypoxaemic respiratory failure in the USA (TESICO): a randomised, placebo-controlled trial The Lancet Respiratory Medicine
Pacemaker Implantation Associated with Tricuspid Repair in the Setting of Mitral Valve Surgery: Insights from a Cardiothoracic Surgical Trials Network Randomized Trial The Journal of Thoracic and Cardiovascular Surgery
Intimal hyperplasia, saphenous vein graft disease, and clinical outcomes: Insights from the CTSN VEST randomized trial The Journal of Thoracic and Cardiovascular Surgery
Tixagevimab–cilgavimab for treatment of patients hospitalised with COVID-19: a randomised, double-blind, phase 3 trial The Lancet Respiratory Medicine
Efficacy and Safety of Ensovibep for Adults Hospitalized With COVID-19 : A Randomized Controlled Trial Annals of Internal Medicine
A Randomized Trial of Mesenchymal Stromal Cells for Moderate to Severe ARDS from COVID-19 American Journal of Respiratory and Critical Care Medicine
External Support for Saphenous Vein Grafts in Coronary Artery Bypass Surgery: A Randomized Clinical Trial JAMA Cardiology
Concomitant Tricuspid Repair in Patients with Degenerative Mitral Regurgitation The New England Journal of Medicine
Efficacy and safety of two neutralising monoclonal antibody therapies, sotrovimab and BRII-196 plus BRII-198, for adults hospitalised with COVID-19 (TICO): a randomised controlled trial The Lancet Infectious Diseases
A Neutralizing Monoclonal Antibody for Hospitalized Patients with COVID-19 The New England Journal of Medicine
Intramyocardial Injection of Mesenchymal Precursor Cells and Successful Temporary Weaning From Left Ventricular Assist Device Support in Patients With Advanced Heart Failure: A Randomized Clinical Trial The Journal of the American Medical Association
Effect of Cerebral Embolic Protection Devices on CNS Infarction in Surgical Aortic Valve Replacement: A Randomized Clinical Trial The Journal of the American Medical Association
Two-Year Outcomes of Surgical Treatment of Moderate Ischemic Mitral Regurgitation The New England Journal of Medicine
Hybrid Coronary Revascularization for the Treatment of Multivessel Coronary Artery Disease: A Multicenter Observational Study Journal of the American College of Cardiology
Rate Control versus Rhythm Control for Atrial Fibrillation after Cardiac Surgery The New England Journal of Medicine
Two-Year Outcomes of Surgical Treatment of Severe Ischemic Mitral Regurgitation The New England Journal of Medicine
Predicting recurrent mitral regurgitation after mitral valve repair: A difficult endeavor and a necessity The Journal of thoracic and cardiovascular surgery
Surgical Ablation of Atrial Fibrillation during Mitral-Valve Surgery The New England Journal of Medicine
Mesenchymal precursor cells as adjunctive therapy in recipients of contemporary left ventricular assist devices Circulation - American Heart Association
Surgical Treatment of Moderate Ischemic Mitral Regurgitation The New England Journal of Medicine
Management practices and major infections after cardiac surgery Journal of the American College of Cardiology
Mitral-valve repair versus replacement for severe ischemic mitral regurgitation The New England Journal of Medicine